Vaccine Potency
The Effect of Inadequate Cold Chain on Rabies Vaccine Potency
84
Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins
10
Improving DNA Vaccine Potency by Linking Marek's Disease Virus Type 1 VP22 to an Antigen
7
Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation
10
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage of Herpes Simplex Virus Type 1 VP22 Protein to Antigen
9
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling
19
Combined Administration with DNA Encoding Vesicular Stomatitis Virus G Protein Enhances DNA Vaccine Potency
9
Selection of Adjuvants for Enhanced Vaccine Potency
46
Determination of Factors Affecting Bivalent (Type 1 and 3) Stability of Oral Poliomyelitis Vaccine
8
Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves
22
N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for Potency Testing and Immune Processing
22
Analysis of Multiple Leptospira interrogans Serovar Canicola Vaccine Proteomes and Identification of LipL32 as a Biomarker for Potency
7
Delivery Systems for Gene-based Vaccines
10
PREPARATION AND EVALUATION OF MULTIPLE-UNIT GASTRO RETENTIVE FLOATING DRUG DELIVERY SYSTEM FOR ONDANSETRON HYDROCHLORIDE BASED ON GAS FORMATION TECHNIQUE
7
Potency of a vaccine prepared from A/swine/Hokkaido/2/1981 (H1N1) against A/Narita/1/2009 (H1N1) pandemic influenza virus strain
8
In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2 Mouse Model
9
Improving the potency of DNA vaccine against Chicken Anemia Virus (CAV) by fusing VP1 protein of CAV to Marek's Disease Virus (MDV) Type 1 VP22 protein
9
Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells
14
Variable Efficacy of Glucocorticoids in Congenital Adrenal Hyperplasia
8
Pattern of utilization of corticosteroids in department of dermatology at a tertiary care teaching hospital
6